GENERAL COMMENTARY article

Front. Pharmacol., 23 July 2013

Sec. Pharmacology of Ion Channels and Channelopathies

Volume 4 - 2013 | https://doi.org/10.3389/fphar.2013.00094

Erratum: Interfering amino terminal peptides and functional implications for heteromeric gap junction formation

  • EC

    Eric C. Beyer 1

  • XL

    Xianming Lin 2

  • RD

    Richard D. Veenstra 2*

  • 1. Department of Pediatrics, University of Chicago Chicago, IL, USA

  • 2. Department of Pharmacology, SUNY Upstate Medical University Syracuse, NY, USA

There was an inadvertent error in Figure 4, panel (F), pertaining to the effect of the iNT-Cx50a peptide on the spermine block of rat Cx40 gap junctions. The data that originally appeared in this figure was the same data plotted in Figure 4, panel (B) for the iNT-Cx40b peptide. The data in Figure 4B is correct and the correct data for the iNT-Cx50a (n = 4) is now illustrated in this revised version of Figure 4 for the original manuscript. The corresponding author regrets the error that occurred while configuring the figures for this manuscript and accepts sole responsibility for this mistake. The iNT-Cx50a peptide was 95% effective in preventing the inhibition of Cx40 gap junctions by 500 microM spermine and inclusion of the correct data for the iNT-Cx50a peptide does not alter the results or conclusion of the original manuscript, just the accuracy of reporting the experimental data. The legend for Figure 4 is not affected in any way and is reproduced here in its entirety.

Figure 4

Summary

Keywords

connexin43, connexin40, gap junction, Heteromeric channel, Spermine

Citation

Beyer EC, Lin X and Veenstra RD (2013) Erratum: Interfering amino terminal peptides and functional implications for heteromeric gap junction formation. Front. Pharmacol. 4:94. doi: 10.3389/fphar.2013.00094

Received

26 June 2013

Accepted

04 July 2013

Published

23 July 2013

Volume

4 - 2013

Edited by

Harry Fozzard, The University of Chicago, USA

Copyright

*Correspondence:

This article was submitted to Frontiers in Pharmacology of Ion Channels and Channelopathies, a specialty of Frontiers in Pharmacology.

Disclaimer

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Figures

Cite article

Copy to clipboard


Export citation file


Share article

Article metrics